ATP5MK and schizophrenia: Furthermore, altered ATP5MD expression in schizophrenia was also observed in the Common Mind Consortium (CMC, minimal P = 0.005)34 and in the Lieber Institute for Brain Development (LIBD, minimal P = 0.008)35 datasets (Dataset 3).